Random Access Under Variable Sample Volumes: An Indian Laboratory Perspective

The Indian Context

Many Indian laboratories, particularly in tier-2 and tier-3 cities, handle:

• Low daily sample volumes: 5-20 samples per day for specialized tests
• variable volumes: Unpredictable daily fluctuations
• Budget constraints: Limited capital and operating budgets
• Staff limitations: Limited technical staff for instrument operation

Why Random Access Matters

For laboratories with variable sample volumes, batch-mode testing is problematic:

• Accumulation delays: Waiting to fill a batch of 24-96 samples can take days
• Reagent waste: Running partial batches wastes reagents
• TAT impact: Turnaround time increases significantly

Random Access addresses these issues by allowing:

• Immediate testing: Run samples as they arrive
• No minimum batch size: Test 1 sample or 20
• Flexible scheduling: Prioritize urgent samples
• Reduced reagent waste: Only use what you need

Cost-Per-Test Considerations

While Random Access reduces waste, the cost-per-test may be higher than batch mode due to:

• Higher per-test reagent costs (no bulk discount)
• Fixed overhead per run (controls, calibration)
• Potential for more frequent calibration

Cost Calculation Framework

Effective Cost per Test = 
  (Reagent cost per test + Control cost per test) + 
  (Calibration overhead / samples per calibration cycle) + 
  (Instrument depreciation / annual test volume)

Recommendations for Indian Laboratories

1. Calculate your effective daily volume: Average over 3-6 months
2. Assess volatility: Track daily variation coefficient
3. Compare platforms: Evaluate both batch and Random Access options
4. Negotiate pricing: Seek volume-flexible reagent pricing
5. Plan for growth: Consider scalability for future volume increases

Manufacturer Claims vs. Reality

Kunpeng Gene / iFIND claims Random Access capability. However, the actual minimum run size, cost structure, and turnaround time per sample in low-volume settings require practical verification.